Teva concludes $703m women's health products deal with CVC Capital - Pharmaceutical Technology
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva Receives FDA Approval for Migraine Autoinjector | Ctech
Teva will appeal opioid liability ruling in New York trial -
Teva Announces Nationwide Opioids Settlement to Move Forward After Receiving Broad Support from States | Business Wire
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva Stock Higher After Buffett's Bump
Teva Pharmaceuticals - Wikipedia
Why Teva Pharmaceuticals Stock Has Two A-Products In The Bag (NYSE:TEVA) | Seeking Alpha
Teva down as it reports lower sales and profit for 2018
Teva Pharmaceuticals Moving U.S. Headquarters To New Jersey
TEVA | Market Realist
Teva Pharmaceutical Stock: Gem Among Generic Pharma Companies (NYSE:TEVA) | Seeking Alpha
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
Teva stock drops on guidance, manufacturing problems - MarketWatch
Award of Merit Manufacturing: TEVA Biologics Manufacturing Facility | 2018-10-16 | Engineering News-Record
Teva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook Warning - WSJ
Teva Pharmaceuticals to lay off 14,000 employees worldwide, 1,750 in Israel - The Jerusalem Post
Teva introduces QVAR RediHaler inhalation aerosol in US - Pharmaceutical Technology
Pharma giant Teva promises to create over 800 jobs in N.J. Are they worth $40M? - nj.com
Teva Pharmaceutical reports Q1 2018 | AlphaStreet
$40 million incentive lures global pharmaceutical giant to Parsippany
Patients Eagerly Awaited a Generic Drug. Then They Saw the Price. - The New York Times
Teva loses bid to cancel Corcept drug patent at Federal Circuit | Reuters
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/2TEN37HNUZDLHM244F4YUG32S4.jpg "Teva Pharmaceutical will cut 7,000 jobs and close plants to reduce costs")
Teva Pharmaceutical will cut 7,000 jobs and close plants to reduce costs
Teva Says 2018 Profit Will Keep Falling as Generic Drug Slump Persists - Bloomberg
